generics
AstraZeneca sues FDA over generic Seroquel
March 14, 2012Manufacturing and Production, Sales and Marketing AstraZeneca, FDA, Seroquel, US, generics
AstraZeneca has said it filed a lawsuit against the US FDA in a bid to block approval of generic versions …
Ranbaxy launches generic Lipitor in Europe
March 6, 2012Research and Development, Sales and Marketing Lipitor, Pfizer, Ranbaxy, atorvastatin, generics
Ranbaxy has launched its generic version of Pfizer’s Lipitor in Europe, months ahead of its May expiration date. The Indian …
Pfizer closes in on $545m China generics deal
February 20, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing China, Hisun, Pfizer, Zhejiang, generics
Pfizer has moved a step closer to a deal with Shanghai-based Zhejiang Hisun Pharmaceutical to develop generic drugs in China. …
Hospira faces lawsuits from disgruntled investors
January 9, 2012Manufacturing and Production Hospira, generics, manufacturing
Angry investors in US generic drugmaker Hospira have filed a class action lawsuit against the company, alleging that it misled …
Pfizer hatches mail order plan for Lipitor
November 23, 2011Sales and Marketing Lipitor, Pfizer, US, generics
Pfizer is preparing to launch a new mail order service offering cut-price Lipitor direct to patients in the US.The firm …
Teva sees modest growth as US sales fall
November 3, 2011Business Services, Sales and Marketing Teva, generics
Sales growth at Teva was modest in Q3, rising 2% to $4.34 billion, with growth predominately coming from branded drugs.This …
Dr Reddy’s says two plants clear FDA inspections
October 28, 2011Manufacturing and Production Dr Reddy's, FDA 483s, India, generics
Two manufacturing facilities operated by Indian drugmaker Dr Reddy’s Laboratories successfully passed inspections by the FDA, although a plant in …
Health service’s £1bn patent expiry windfall
October 14, 2011Sales and Marketing generics, patent expiry
Patent expiries could shave £1 billion from the NHS drugs bill, and could yield major savings by 2015 for the …
Actavis plans ‘major’ sales expansion in Latin America
October 6, 2011Sales and Marketing Actavis, emerging markets, generics
Swiss company Actavis has launched a new business unit to target the fast-growing Latin American generics market. Mirroring the branded …
AZ’s Nexium faces generic competition in the UK
September 6, 2011Nexium, Ranbaxy, generics
Generic specialist Ranbaxy has launched its version of AstraZeneca’s anti-ulcer blockbuster Nexium in the UK. It will be available in …
Spain to cut 2.4 billion euros from drugs bill with new generics rules
August 24, 2011Sales and Marketing Spain, generic prescribing, generics
The Spanish government has passed new laws to increase generic prescribing and cut billions of euros from the country’s drugs …
Generic user fees could boost FDA inspection powers
August 22, 2011Manufacturing and Production Mylan, generics, pharma manufacturing news
Generic drugmakers have forged a tentative deal with the US government that could see user fees being used to help …
Pfizer triumphs in US Viagra patent trial
August 17, 2011Sales and Marketing Pfizer, generics, viagra
Pfizer has won a US patent infringement case against generics giant Teva, stopping the company from making its own version …
UK suing Servier over alleged generic blocking
June 7, 2011Sales and Marketing Peridopril, Servier, generics
The UK government is taking Servier to court for allegedly blocking generic versions of its blood pressure drug Perindopril from …
Teva plans Japan expansion with Taiyo buy
May 17, 2011Sales and Marketing Taiyo, Teva, generics
Teva is to acquire a majority stake in Taiyo, Japan’s third largest generics company for $460 million in cash. The …
Latest content
Five Facts about cardiovascular disease
